Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial.
- DOI
- 10.1136/jitc-2024-010094
- Published
- 2024 Dec 4
- Container
- Journal for immunotherapy of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2024-010094,
title = {Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial.},
author = {Ma LX and Titmuss E and Loree JM and Jonker DJ and Kennecke HF and Berry S and Couture F and Ahmad CE and Goffin JR and Kavan P and Harb M and Colwell B and Samimi S and Samson B and Abbas T and Aucoin N and Aubin F and Koski S and Tu D and O'Callaghan C and Chen EX},
year = {2024},
journal = {Journal for immunotherapy of cancer},
doi = {10.1136/jitc-2024-010094},
url = {https://doi.org/10.1136/jitc-2024-010094}
}RIS
TY - JOUR TI - Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial. AU - Ma LX AU - Titmuss E AU - Loree JM AU - Jonker DJ AU - Kennecke HF AU - Berry S AU - Couture F AU - Ahmad CE AU - Goffin JR AU - Kavan P AU - Harb M AU - Colwell B AU - Samimi S AU - Samson B AU - Abbas T AU - Aucoin N AU - Aubin F AU - Koski S AU - Tu D AU - O'Callaghan C AU - Chen EX PY - 2024 JO - Journal for immunotherapy of cancer DO - 10.1136/jitc-2024-010094 UR - https://doi.org/10.1136/jitc-2024-010094 ER -
APA
LX, M., E, T., JM, L., DJ, J., HF, K., S, B., F, C., CE, A., JR, G., P, K., M, H., B, C., S, S., B, S., T, A., N, A., F, A., S, K., D, T., C, O., & EX, C. (2024). Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2024-010094
Source records
- pubmed · retrieved 2026-09-26T14:27:23.038Z
- europe-pmc · retrieved 2026-09-26T14:27:23.035Z
- doaj · retrieved 2026-09-26T14:27:23.013Z